Aurinia Pharmaceuticals (AUPH) Raw Materials (2023 - 2026)

Aurinia Pharmaceuticals' Raw Materials history runs 4 years deep, the most recent figure standing at $658000.0 for Q1 2026.

• Quarterly Raw Materials fell 14.66% year-over-year to $658000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $658000.0 (down 14.66% YoY) and the FY2025 annual result came in at $658000.0, down 61.34% from the prior year.
• Raw Materials was $658000.0 for Q1 2026 at Aurinia Pharmaceuticals, roughly flat from $658000.0 in the prior quarter.
• Across five years, Raw Materials topped out at $1.7 million in Q4 2023 and bottomed at $658000.0 in Q4 2025.
• A 4-year average of $1.0 million and a median of $771000.0 in 2025 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials slipped 2.52% — and 2025, when it plunged 61.34%.
• Aurinia Pharmaceuticals' Raw Materials stood at $1.7 million in 2023, then dropped by 2.52% to $1.7 million in 2024, then slumped by 61.34% to $658000.0 in 2025, then changed by 0.0% to $658000.0 in 2026.
• Business Quant data shows AUPH's Raw Materials at $658000.0 in Q1 2026, $658000.0 in Q4 2025, and $771000.0 in Q3 2025.